Selected
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
2594 results found
2023 ∙ Watanabe, A. Iwagami, M. Yasuhara, J. Takagi, H. Kuno, T.
Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis
  • Vaccine/vaccination
  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Bobrovitz, N. Ware, H. Ma, X. Li, Z. Hosseini, R. Cao, C. Selemon, A. Whelan, M. Premji, Z. Issa, H. Cheng, B. Abu Raddad, L. J. Buckeridge, D. L. Van Kerkhove, M. D. Piechotta, V. Higdon, M. M. Wilder-Smith, A. Bergeri, I. Feikin, D. R. Arora, R. K. Patel, M. K. Subissi, L.
Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression
  • Vaccine/vaccination
  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Administration
Rating:
Critically low
2023 ∙ Wu, Chi-Fang Highfield, Linda Swint, John M. Lairson, David R.
Provider-Based HPV Vaccine Promotion Interventions: A Meta-analysis
  • Adolescents
  • Adults
  • Human papillomavirus (HPV)
  • Acceptance
Rating:
Not applicable
2023 ∙ Xu, S. Li, J. Wang, H. Wang, F. Yin, Z. Wang, Z.
Real-world effectiveness and factors associated with effectiveness of inactivated SARS-CoV-2 vaccines: a systematic review and meta-regression analysis
  • Vaccine/vaccination
  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Rating:
Low
2023 ∙ Beran, A. Mhanna, A. Mhanna, M. Hassouneh, R. Abuhelwa, Z. Mohamed, M. F. H. Sayeh, W. Musallam, R. Assaly, R. Abdeljawad, K.
Real-world effectiveness of COVID-19 vaccination in liver cirrhosis: a systematic review with meta-analysis of 51,834 patients
  • Vaccine/vaccination
  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Palalay, H. Vyas, R. Tafuto, B.
Real-world effectiveness of mRNA COVID-19 vaccines in the elderly during the Delta and Omicron variants: Systematic review
  • Vaccine/vaccination
  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Xu, W. Ren, W. Wu, T. Wang, Q. Luo, M. Yi, Y. Li, J.
Real-World Safety of COVID-19 mRNA Vaccines: A Systematic Review and Meta-Analysis
  • Vaccine/vaccination
  • All age groups
  • Healthcare workers
  • COVID-19
  • Safety
Rating:
Critically low
2023 ∙ Shearn, C. Krockow, E. M.
Reasons for COVID-19 vaccine hesitancy in ethnic minority groups: A systematic review and thematic synthesis of initial attitudes in qualitative research
  • Vaccine/vaccination
  • All age groups
  • COVID-19
  • Acceptance
  • Ethical issues
Rating:
Not applicable
2023 ∙ Goon, P. Sauzet, O. Schuermann, M. Oppel, F. Shao, S. Y. Scholtz, L. U. Sudhoff, H. Goerner, M.
Recurrent Respiratory Papillomatosis (RRP)—Meta-analyses on the use of the HPV vaccine as adjuvant therapy
  • Adults
  • Older adults
  • Human papillomavirus (HPV)
  • Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Cheng, M. Q. Li, R. Weng, Z. Y. Song, G.
Relative effectiveness of bivalent COVID-19 vaccine: a systematic review and meta-analysis
  • Vaccine/vaccination
  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Rating:
Critically low